Corbus Pharmaceuticals Holding (CRBP) Financials

$8.49

$-0.37 (-4.18%)

As on 10-Sep-2026 10:36EDT

Market cap

$214 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

2.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	0.88
Cost of Revenue	0.15	0.23	0.60	31.17	1.49	1.64
Gross Profit	-0.15	-0.23	-0.60	-31.17	-1.49	-0.76
Operating Expenses	106.83	85.31	48.12	45.08	33.35	55.23
Operating Profit (EBIT)	-106.88	-85.31	-48.72	-45.08	-34.84	-55.99
Other Income	--	--	--	--	--	--
Profit before Tax	-101.90	-78.54	-40.21	-44.60	-42.35	-45.64
Provision for Tax	--	--	--	--	13.49	-0.09
Profit after Tax (Net Income)	-101.90	-78.54	-40.21	-44.60	-55.83	-45.55
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-42.35	-45.64

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	102.24	147.50	142.43	-6.91	32.99	69.11
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	3.27	--	1.63	3.28	20.68	21.61
Current Liabilities	21.48	20.69	11.82	31.89	12.64	17.01
Total Liabilities	148.47	168.20	155.88	28.27	66.31	107.73

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	4.24	1.24	2.90	4.73	6.13	7.53
Current Assets	122.75	166.95	152.98	23.55	60.18	100.20
Total Assets	148.47	168.20	155.88	28.27	66.31	107.73
Total Debt*	4.26	1.63	3.24	20.89	25.09	26.59
Net Current Assets	101.27	146.26	141.16	-8.35	47.54	83.20

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-64.49	-41.79	-36,100.47	-37.54	-48.18
Cash Flow from Investing Activities	--	-1.64	-121.31	35,641.96	30.07	-73.42
Cash from Financing Activities	--	77.43	166.58	-2,820.52	-0.53	60.82
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-6.47	-5.90	-3.30	-10.08	-13.39	-10.91
Cash EPS ($)	--	-5.88	-3.25	-9.77	-13.03	-10.52
Adjusted Book Value ($)	--	11.08	11.69	--	7.91	16.56
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-4.84	-3.43	-8,160.70	-9.00	-11.54
Free Cash Flow per Share ($)	--	-4.84	-3.43	-8,160.70	-9.00	-11.56

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-53.28	-50.37	-123.80	-72.62	-54.29
ROE (%)	-81.61	-54.18	-59.34	-341.99	-109.37	-79.65
ROA (%)	-71.04	-48.47	-43.67	-94.32	-64.16	-43.38
EBIT Margin (%)	--	--	--	--	--	-4,968.78
Net Margin (%)	--	--	--	--	--	-5,166.42
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	-1.00	-0.78
EBIT Growth (%)	-71.98	-104.86	5.91	-1.32	8.21	64.33
Net Profit Growth (%)	-75.84	-95.32	9.85	20.11	-22.57	59.06
EPS Growth (%)	-35.88	-0.79	0.67	0.25	-0.23	0.71
Book Value Growth (%)	-41.90	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.38	-3.57	-0.60	-0.01	-0.06
Price / Book Value	2.13	0.73	1.01	-3.87	0.01	0.04
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.17	0.68	0.06	-0.67	0.87	1.62
Close Price ($)	9.38	8.14	11.80	6.04	3.32	18.47
High Price ($)	20.56	20.56	61.90	13.17	20.10	120.00
Low Price ($)	6.72	4.64	5.71	2.11	3.00	17.70
Market Cap ($ Cr)	214.30	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.01	0.02	-3.02	0.76	0.38
Short term debt to equity ratio	0.01	0.01	0.01	-2.56	0.13	0.07
Current Ratio	5.71	8.07	12.94	0.74	4.76	5.89
Quick Ratio	5.71	--	--	--	--	--
Interest Coverage	--	--	-20.48	-13.94	-18.86	-23.93

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	0.01
Receivable days	--	--	--	--	--	1,068.08
Inventory Days	--	--	--	--	--	77.99
Payable days	--	5,487.37	2,424.35	31.37	485.60	1,020.89
Cash Conversion Cycle	--	--	--	--	--	125.18

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.